3. Shigella

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/29

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

30 Terms

1
New cards

Shigella vaccine

Some clinical trials but no

2
New cards

Shigella sonnei

the most common species in the US and other high-
income countries
, generally causes milder disease

3
New cards

Shigella flexneri

widespread in low- and middle-income countries

4
New cards


Shigella boydii

very rare in the US, most cases occur in India

5
New cards


Shigella dysenteriae

very rare in the US, most cases occur in Africa,
can lead to
death

6
New cards

Shigella transmission

usually through
the
fecal-oral route, meaning that
Shigella is transmitted by eating
small amounts of feces

7
New cards

Hemolytic uremic syndrome

a serious condition that can occur after Shigella infection, characterized by anemia, low platelet count, and acute kidney failure.

8
New cards

The genomes of Shigella and Enteroinvasive E. coli (EIEC

VERY SIMILAR
have a 230 kb virulence plasmid with the mxi-spa
locus
which encodes a T3SS

9
New cards

similarity observed across
the Shigella species is the result of

convergent evolution

10
New cards

Shigella pathogenicity
islands (SHI PAIs)

carry virulence factors

11
New cards

Mxi-Spa T3SS

plasmid-
encoded, and
also found in EIEC to secrete effectors into host cell

12
New cards

How does shigella invade from the intestinal lumen 

invade via M cells (microfold cells) and use transcytosis to cross the epithelium

13
New cards

M cells

specialized intestinal epithelial cells that sample the intestinal microbiota

14
New cards

How does Shigella enter host cells


uses a
trigger mechanism to induce membrane ruffling like Salmonella

15
New cards

Shigella Mxi-Spa T3SS- role in invasion

injects the IpaABC effectors which activate Rho GTPases to allow actin cytoskeleton remodeling for membrane ruffling

16
New cards


Shigella-containing vacuole

a vacuole formed after Shigella invasion, which facilitates bacterial survival and replication within the host cell.

17
New cards

M cell pocket

A specialized region in the intestinal mucosa where M cells capture and transport antigens to immune cells, facilitating the entry of Shigella into the host.

18
New cards

IL-8

produced by neighboring
epithelial cells (12) recruits PMNs,
which travel from the basolateral to
the apical colonic epithelium,
destabilizing the junctions between
the epithelial cells and allowing
further invasion of Shigella

19
New cards

How can Shigella spread from cell-cell

actin modification

20
New cards

Cell-to-cell spread is seen in

Shigella, Rickettsia, and Listeria

21
New cards

The IscA and IscB effectors of the T3SS of Shigella


play a large role
in
cell-to-cell spread

22
New cards

IscA

induces actin polymerization to help facilitate cell-cell spread

23
New cards

Shigella immune response

IL-8 weakens junctions to promote spread, BUT also facilitates full clearance

24
New cards

Shiga toxin

depurinates (removes a purine, adenine) from ribosomal
RNA and
inhibits protein synthesis

25
New cards

ShET1 and ShET2

are not homologous, but both are exotoxins that
cause
fluid secretion and watery diarrhea

26
New cards


S. dysenteriae produces

Shiga AB5 toxin to inhibit protein synthesis

27
New cards

Shiga toxin- B subunit

binds to a host glycolipid (GB3 in
figure) that is found mainly on kidney epithelial
cells (HUS)

28
New cards

Shiga toxin- A subunit 

released into the
cytosol where it
removes an adenine from
ribosomal RNA
and blocks protein synthesis

29
New cards

4 Shigella species are differentiated based on
biochemical tests and their

LPS O antigen

30
New cards

Shigella vaccine candidate

engineered Shigella to
produce the 4 most common LPS
serogroups and to excessively form
OMVs, which will deliver the 4 component O antigen vaccine